Polymorphisms of IL-18 promoter, another proinflammatory cytokine released upon NLRP3 inflammasome activation, has been shown to be associated to the risk of developing sporadic late onset AD [160]. The gene discussed is NLRP3; the disease is Alzheimer disease.